InvestorsHub Logo
Followers 22
Posts 899
Boards Moderated 0
Alias Born 07/24/2002

Re: Grateful post# 13834

Sunday, 04/11/2004 8:29:56 PM

Sunday, April 11, 2004 8:29:56 PM

Post# of 82595
Grateful...The first trial you mention involves both drugs mentioned in the Moffitt PR (Xeliri and Xelox).

Cetuximab is, of course, better known as Erbitux (of Imclone/Martha Stewart fame). It is a monoclonal antibody that has shown ability in some patients to shrink tumors.

Whether or not these are "the" studies they are involved in is impossible to say...

Later,
W2P